HomeCompaniesProfile

Gilgamesh Pharmaceuticals

Gilgamesh Pharmaceuticals, a Clinical stage biotechnology company… 


Company Size

11 - 50 employees

Year Founded

2019


About Gilgamesh Pharmaceuticals

Gilgamesh is a pioneering, clinical stage mental health science-focused biotechnology company. We have a disciplined focus on developing innovative new chemical entities (NCEs) leveraging a unique combination of medicinal chemistry, intellectual property strategy, neuroscience & neurobiology, and drug development expertise. We are an experienced team, with proven success in biotech exits and inventions.

Founders & Key People

Dalibor Sames

Dalibor Sames

Founder, Gilgamesh Pharmaceuticals

JONATHAN SPORN

JONATHAN SPORN

Founder, Gilgamesh Pharmaceuticals

Andrew Kruegel

Andrew Kruegel

Founder, Gilgamesh Pharmaceuticals

Share This Profile

More Companies

SINAI

Enterprise software to quantify cost-effective decarbonization…

Aerotime

Calendar that kills time fragmentation

Dendron

Nimbus reduces Datadog costs by more than 60% without Manual Effort

CodeHS

CodeHS is a comprehensive platform helping schools teach computer…

PNOĒ

Enabling health professionals to prescribe clinical-grade wellness…

Boundary Layer Technologies

Cutting edge hydrofoil systems for boatbuilders

BEAMSTART

BEAMSTART is a global entrepreneurship community, serving as a catalyst for innovation and collaboration. With a mission to empower entrepreneurs, we offer exclusive deals with savings totaling over $1,000,000, curated news, events, and a vast investor database. Through our portal, we aim to foster a supportive ecosystem where like-minded individuals can connect and create opportunities for growth and success.

© Copyright 2026 BEAMSTART. All Rights Reserved.